Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)

From US Department of Health & Human Services: National Institutes of Health (NIH)

The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.

Type of Support

Overview

The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.

Eligibility

Organization's Location
non sit
Program Location
deserunt
Organization Type
up to 2.5M

Submission

Schedule
Step 1: eu proident mollit
Application deadline
Dec 19, 2024
Step 2: occaecat nulla (reprehenderit aliqua)

Similar grants